Old Web
English
Sign In
Acemap
>
Paper
>
Cardiac death should be the primary endpoint for revascularization trials and meta-analyses.
Cardiac death should be the primary endpoint for revascularization trials and meta-analyses.
2021
Harvey D. White
Keywords:
Revascularization
Cardiology
Clinical endpoint
Internal medicine
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
5
References
1
Citations
NaN
KQI
[]